TAYLOR HAWKINS: Open Payments
NPI 1194320259 · CHAPEL HILL, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 61 payments from 11 companies in 2025. Trend: 2023 $554 · 2024 $906 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $295 |
| Teva Pharmaceuticals USA, Inc. | 25 | $207 |
| PFIZER INC. | 5 | $113 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Valinor Pharma, LLC | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
Products named: VRAYLAR, UZEDY, NURTEC ODT, AUSTEDO XR, SPRAVATO, QULIPTA, Belbuca, REXULTI.
Industry payments across NC — which companies pay providers there.
